Developing vaccines and biologics for infectious diseases
Official title: Task V29: STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID
Funded at International AIDS Vaccine Initiative · NIH-10490542 · Data updated 2026-11-12
This study is working on creating new vaccines to help protect people from serious infections, including those that could come from bioterrorism, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2021 |
| Award (this year) | $435,314 |
| NIH project number | 272201800010I-0-759302100001-1 |
| Project ID | NIH-10490542 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases or those involved in clinical trials for new vaccines.
✕Less likely to help
Patients with established immunity to the targeted infectious diseases or those not at risk may not receive direct benefits from this research.
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism. It involves planning and feasibility assessments, as well as compliant manufacturing processes for early-phase clinical studies. The project also includes toxicology studies and regulatory support to ensure that new vaccines meet FDA standards. Patients may benefit from the introduction of new vaccines that protect against serious infectious threats.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from infectious diseases and bioterrorism threats.
How similar studies have gone: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Developing and producing new vaccines for infectious diseases.
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.